The company is aiming to create a suite of products that can help researchers and manufacturers engineer various genomes at scale for multiple purposes.
During the five-year collaboration, the partners will research disease-causing gene mutations and develop new CRISPR-based technologies for drug discovery.
Researchers from the Broad Institute and NIH characterized a CRISPR-associated transposase that can integrate DNA into unique sites in the E. coli genome.
In Nucleic Acids Research: software for analyzing transcriptomic and proteomic data, Fido-SNP tool for predicting consequences of SNVs in the dog genome, and more.
In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.
